powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1346774015
Michael Weintraub
MD
Endocrinology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$411
Payment records
5
By payment type
Food and Beverage
$411
QUALITY · MIPS · 2024
Final MIPS score
90.8
Quality
91.8
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.66%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,326
Beneficiaries
—
Total drug cost
$1.9M
Distinct drugs
26
Brand share
64.7%
Top prescribed drugs
Levothyroxine Sodium
184 claims
Metformin Hcl
149 claims
Tirzepatide
138 claims
Levothyroxine Sodium
123 claims
Semaglutide
119 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
639
Unique beneficiaries
—
Total services
932
Distinct HCPCS
8
Medicare payment
$65K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — above median (cohort median 837).